01 · ABSTRACT
Abstract
The convergence of artificial intelligence, personalized medicine, and Patient Benefit Management (PBM) marks a major change in modern healthcare administration. In the past, PBM systems have relied on population-averaged benefit models, with consistent coverage rules, formulary designs, and authorization procedures across patient groups. This method is fundamentally mismatched with the biological individuality that affects treatment responses, disease progression, and healthcare costs. This paper explores how AI-driven personalized medicine-including genomic data, pharmacogenomics, biomarker-guided care, and adaptive clinical decision support-can be integrated into PBM structures. The goal is to develop precise benefit systems that tailor coverage decisions, improve formulary design, prevent avoidable adverse events, and connect financial incentives with patient-specific, clinically validated treatment options.
This analysis explores the data integration frameworks, machine learning architectures, and governance structures necessary to transform PBM from a reactive administrative function into a proactive, personalized care enablement platform. By addressing current AI capabilities, implementation strategies, regulatory requirements, and measurable clinical and economic outcomes achievable through precision benefit design, this paper offers healthcare payers, benefit administrators, technology architects, and clinical leaders a comprehensive roadmap for deploying AI-powered personalized PBM systems that improve patient outcomes, reduce unnecessary therapeutic expenditure, and promote health equity across diverse patient populations.
↓ Read PDF02 · OJS METADATA
Keywords
Personalized MedicinePatient Benefit ManagementPharmacogenomicsAI-Driven BenefitsPrecision FormularyGenomic Decision SupportAdaptive Prior AuthorizationPredictive Benefit Optimization.
03 · PUBLICATION RECORD
Article details
JournalMedical Research Archives
IssueVol 14 No 5 (2026): Vol.14 Issue 5 May 2026
SectionPolicy Articles
Published01 June 2026
DOI10.18103/mra.v14i5.7495
ISSN2375-1924
04 · RIGHTS & REUSE
Rights & reuse
This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.